These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 14474953)

  • 1. Clinical pharmacology of antianginal drugs.
    MODELL W
    Clin Pharmacol Ther; 1962; 3():97-108. PubMed ID: 14474953
    [No Abstract]   [Full Text] [Related]  

  • 2. Symposium on clinical drug evaluation and human pharmacology. XII. Assessment of antianginal agents.
    RINZLER SH
    Clin Pharmacol Ther; 1962; 3():505-9. PubMed ID: 14492395
    [No Abstract]   [Full Text] [Related]  

  • 3. Assay of antianginal agents; the rapport period.
    COLE SL; KAYE H; GRIFFITH GC
    J Am Med Assoc; 1958 Sep; 168(3):275-7. PubMed ID: 13575155
    [No Abstract]   [Full Text] [Related]  

  • 4. EXPERIMENTAL APPROACHES TO THE DEVELOPMENT OF ANTIANGINAL DRUGS.
    WINBURY MM
    Adv Pharmacol (1962); 1964; 3():1-82. PubMed ID: 14236560
    [No Abstract]   [Full Text] [Related]  

  • 5. An investigation of the pharmacological treatment of angina pectoris.
    GANZ V; FRONEK A; HAMMER J
    Rev Czech Med; 1962; 8():137-42. PubMed ID: 13896706
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical pharmacology of nitrites].
    OBERGASSNER
    Med Monatsschr; 1952 Oct; 6(10):646-50. PubMed ID: 13012804
    [No Abstract]   [Full Text] [Related]  

  • 7. Stable angina pectoris: current medical treatment.
    Siama K; Tousoulis D; Papageorgiou N; Siasos G; Tsiamis E; Bakogiannis C; Briasoulis A; Androulakis E; Tentolouris K; Stefanadis C
    Curr Pharm Des; 2013; 19(9):1569-80. PubMed ID: 23016717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of antianginal effects of running pulse magnetic field and drug therapy on the physical working capacity and hemodynamics in patients with stable angina pectoris].
    Orlov LL; Makoeva LD; Glezer MG; Titov SIu; Arzhanenko OM; Margarian AG; Musev VA; Memetov KA; Belinskaia TF
    Kardiologiia; 1992 Feb; 32(2):23-6. PubMed ID: 1527930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of angina pectoris: evaluation of anti-anginal agents and procedures.
    COLE SL
    Dis Chest; 1958 Sep; 34(3):330-4. PubMed ID: 13574042
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of stable angina pectoris.
    Palaniswamy C; Aronow WS
    Am J Ther; 2011 Sep; 18(5):e138-52. PubMed ID: 20861717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental and early investigational drugs for angina pectoris.
    Elgendy IY; Winchester DE; Pepine CJ
    Expert Opin Investig Drugs; 2016 Dec; 25(12):1413-1421. PubMed ID: 27791405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment of angina pectoris: clinical and instrumental evaluation of an anti-anginal drug combination].
    MALFANTI PL
    Minerva Med; 1960 Oct; 51():3578-85. PubMed ID: 13765767
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of drug therapy of angina pectoris.
    PORDY L; CHESKY K
    Trans Am Coll Cardiol; 1952; 2():128. PubMed ID: 13049502
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evidence-based optimal treatment strategy of patients with angina pectoris].
    Jánosi A
    Orv Hetil; 2008 Feb; 149(7):293-8. PubMed ID: 18258559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term benefits and limitations of combined antianginal drug therapy in elderly patients with symptomatic chronic coronary artery disease.
    Bonetti PO; Kaiser C; Zellweger MJ; Grize L; Erne P; Schoenenberger RA; Pfisterer ME;
    J Cardiovasc Pharmacol Ther; 2005 Mar; 10(1):29-37. PubMed ID: 15821836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic approach to refractory angina.
    Khan SN; Dutka DP
    Curr Opin Support Palliat Care; 2008 Dec; 2(4):247-51. PubMed ID: 19060562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the use of ethaverine in the treatment of angina pectoris.
    SIMON DL; IGLAUER A; SCOTT RC
    Am Heart J; 1954 Oct; 48(4):624-8. PubMed ID: 13197291
    [No Abstract]   [Full Text] [Related]  

  • 18. [Causes of Angina Pectoris in Survivors of Myocardial Infarction and the Role of Optimization of Antianginal Therapy. Data of the LINKOR Study E..].
    Glezer MG; Astashkin On Behalf Of The Linkor Study Investigators EI
    Kardiologiia; 2016 Dec; 56(11):5-11. PubMed ID: 28290813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CLINICAL PHARMACOLOGY. 1. CLINICAL ASPECTS OF DRUGS FOR THE TREATMENT OF ANGINA PECTORIS].
    SUZUKI T
    Naika; 1963 Aug; 12():337-42. PubMed ID: 14050934
    [No Abstract]   [Full Text] [Related]  

  • 20. [Guidelines and methods for clinical investigation of drugs for treatment of stable angina pectoris].
    Wink K
    Arzneimittelforschung; 2003; 53(12):864-8. PubMed ID: 14732968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.